Merck & Co., Inc. — Director's Dealing 2019

Jan 10, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-01-01

Reporting Person: Nally Michael (EVP, Chief Marketing Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	1365.9535	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2021-05-04	Common Stock (3896.0000)		Direct
Restricted Stock Unit	$	2020-05-05	Common Stock (2345.0000)		Direct
Restricted Stock Unit	$	2019-05-10	Common Stock (1811.0000)		Direct
Restricted Stock Unit	$	2021-10-30	Common Stock (6862.0000)		Direct
Stock Option (right to buy)	$54.6800	2026-05-09	Common Stock (7471.0000)		Direct
Stock Option (right to buy)	$57.7500	2028-05-03	Common Stock (27447.0000)		Direct
Stock Option (right to buy)	$63.9700	2027-05-04	Common Stock (14266.0000)		Direct

Footnotes

F1: Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

F5: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.

F6: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F7: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020.